1. Moreno JC, Fernández A, Ortiz JA, Montalvo JJ. Complication rates associated with different treatments for mandibular fractures. J Oral Maxillofac Surg. 2000;58(3):273-80; discussion 280-1. [ DOI:10.1016/S0278-2391(00)90051-X] [ PMID] 2. Malanchuk, V.O. and A.V. Kopchak, Risk factors for development of infection in patients with mandibular fractures located in the tooth-bearing area. Craniomaxillofac Surg. 2007. 35(1):57-62. [ DOI:10.1016/j.jcms.2006.07.865] [ PMID] 3. Shankar DP, Manodh P, Devadoss P, Thomas TK. Mandibular fracture scoring system: for prediction of complications. Oral Maxillofac Surg. 2012;16(4):355-60. [ DOI:10.1007/s10006-012-0326-9] [ PMID] 4. Tabrizi R, Pourdanesh F, Khoshnik PL, Centenero SA. Does the Lag Time Between Injury and Treatment Play a Role in Recovery of Inferior Alveolar Nerve Neurosensory Disturbances Following Mandibular Body Fracture? J Craniofac Surg. 2019;30(7):2128-30. [ DOI:10.1097/SCS.0000000000005621] [ PMID] 5. Eisenstein, T.K., The role of opioid receptors in immune system function.Front. immunol. 2019;10:2904. [ DOI:10.3389/fimmu.2019.02904] [ PMID] [ ] 6. Franchi S, Moschetti G, Amodeo G, Sacerdote P. Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies. Front Immunol. 2019;10:2914. [ DOI:10.3389/fimmu.2019.02914] [ PMID] [ ] 7. Serena-Gómez, E. and L.A. Passeri, Complications of mandible fractures related to substance abuse. J Oral Maxillofac Surg. 2008;66(10):2028-34. [ DOI:10.1016/j.joms.2008.06.022] [ PMID] 8. Kent S, Adatia A, James P, Bains K, Henry A, Blore C, Dawoud B, Kumar D, Jefferies C, Kyzas P; MTReC Collaborators:. Risk factors associated with short-term complications in mandibular fractures: the MANTRA study-a Maxillofacial Trainee Research Collaborative (MTReC). Oral Maxillofac Surg. 2023;27(4):609-16. 9. Daar DA, Kantar RS, Cammarata MJ, Rifkin WJ, Alfonso AR, Wilson SC, Rodriguez ED. Predictors of Adverse Outcomes in the Management of Mandibular Fractures. J Craniofac Surg. 2019 Mar/Apr;30(2):571-7. [ DOI:10.1097/SCS.0000000000005195] [ PMID] 10. Ravikumar, C. and M.J.I.J.o.D.R. Bhoj, Evaluation of postoperative complications of open reduction and internal fixation in the management of mandibular fractures: A retrospective study. 2019;30(1):94. 11. Murariu A, Bobu L, Stoleriu S, Zapodeanu D, Morărașu L, Raluca Baciu E. EFFECTS OF ILLICIT DRUG CONSUMPTION ON ORAL HEALTH AND QUALITY OF LIFE: A NARRATIVE REVIEW. Rom. J. Med. Dent. Educ. 2024;13(2):16-23. [ DOI:10.62610/RJOR.2024.3.16.19] 12. 12Shavit Y, Depaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gale RP, Liebeskind JC. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7114-7. [ DOI:10.1073/pnas.83.18.7114] [ PMID] [ ] 13. Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol. 2006 Apr;173(1-2):3-11. [ DOI:10.1016/j.jneuroim.2005.11.009] [ PMID] 14. Khabbazi S, Goumon Y, Parat MO. Morphine Modulates Interleukin-4- or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages. Sci Rep. 2015;5:11389. [ DOI:10.1038/srep11389] [ PMID] [ ] 15. Vassou D, Bakogeorgou E, Kampa M, Dimitriou H, Hatzoglou A, Castanas E. Opioids modulate constitutive B-lymphocyte secretion. Int Immunopharmacol. 2008 ;8(5):634-44. [ DOI:10.1016/j.intimp.2008.01.002] [ PMID] 16. Zhang EY, Xiong J, Parker BL, Chen AY, Fields PE, Ma X, Qiu J, Yankee TM. Depletion and recovery of lymphoid subsets following morphine administration. Br J Pharmacol. 2011;164(7):1829-44. [ DOI:10.1111/j.1476-5381.2011.01475.x] [ PMID] [ ] 17. Martin JL, Charboneau R, Barke RA, Roy S. Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell Immunol. 2010;265(2):139-45. [ DOI:10.1016/j.cellimm.2010.08.002] [ PMID] [ ] |
